Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C→ T polymorphism at the multidrug resistance gene 1

SR Nóvoa, P Barreiro, A Rendón… - Clinical infectious …, 2006 - academic.oup.com
Abstract The 3435C→ T polymorphism at the multidrug resistance gene 1 (MDR1) was
examined in 74 patients with human immunodeficiency virus who initiated atazanavir …
被引用次数：141 相关文章

Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C→ T polymorphism at the multidrug resistance gene 1.

S Rodríguez Nóvoa, P Barreiro, A Rendón, A Barrios… - 2006 - cabidigitallibrary.org
Abstract The 3435C→ T polymorphism at the multidrug resistance gene 1 (MDR1) was
examined in 74 patients with human immunodeficiency virus who initiated atazanavir …

Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C--> T polymorphism at the multidrug resistance gene 1

SR Nóvoa, P Barreiro, A Rendón… - … publication of the …, 2006 - pubmed.ncbi.nlm.nih.gov
The 3435C--> T polymorphism at the multidrug resistance gene 1 (MDR1) was examined in
74 patients with human immunodeficiency virus who initiated atazanavir therapy. The MDR1 …

[引用][C] Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C→ T polymorphism at the multidrug resistance gene 1

SR Nóvoa, P Barreiro, A Rendón… - Clinical Infectious …, 2006 - produccioncientifica.ucm.es

Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C--> T polymorphism at the multidrug resistance gene 1.

P Barreiro, A Rendón, A Barrios, A Corral… - … Diseases: an Official …, 2005 - europepmc.org
The 3435C--> T polymorphism at the multidrug resistance gene 1 (MDR1) was examined in
74 patients with human immunodeficiency virus who initiated atazanavir therapy. The MDR1 …

[引用][C] Plasma Levels of Atazanavir and the Risk of Hyperbilirubinemia Are Predicted by the 3435C-> T Polymorphism at the Multidrug Resistance Gene 1

SR Novoa, P Barreiro, A Rendon, A Barrios… - Clinical Infectious …, 2006 - cir.nii.ac.jp
Plasma Levels of Atazanavir and the Risk of Hyperbilirubinemia Are Predicted by the 3435C->T
Polymorphism at the Multidrug Resistance Gene 1 | CiNii Research CiNii 国立情報学研究所 …
[PDF] researchgate.net

[PDF][PDF] Plasma Levels of Atazanavir and the Risk of Hyperbilirubinemia Are Predicted by the 3435CrT Polymorphism at the Multidrug Resistance Gene

SR Nóvoa, P Barreiro, A Rendón… - Clinical Infectious …, 2006 - researchgate.net
The 3435CrT polymorphism at the multidrug resistance gene 1 (MDR1) was examined in 74
patients with human immunodeficiency virus who initiated atazanavir therapy. The MDR1 …
[PDF] academia.edu

[PDF][PDF] Plasma Levels of Atazanavir and the Risk of Hyperbilirubinemia Are Predicted by the 3435CrT Polymorphism at the Multidrug Resistance Gene

SR Nóvoa, P Barreiro, A Rendón, A Barrios… - Clinical Infectious …, 2006 - academia.edu
The 3435CrT polymorphism at the multidrug resistance gene 1 (MDR1) was examined in 74
patients with human immunodeficiency virus who initiated atazanavir therapy. The MDR1 …

[引用][C] Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C→ T polymorphism at the multidrug resistance gene 1

S RODRIGUEZ NOVOA, P BARREIRO… - Clinical infectious …, 2006 - pascal-francis.inist.fr
Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C→T
polymorphism at the multidrug resistance gene 1 CNRS Inist Pascal-Francis CNRS Pascal …

Plasma Levels of Atazanavir and the Risk of Hyperbilirubinemia Are Predicted by the 3435C→ T Polymorphism at the Multiidrug Resistance Gene 1.

SR Nóvoa, P Barreiro, A Rendón… - Clinical Infectious …, 2006 - search.ebscohost.com
Abstract The 3435C→ T polymorphism at the multidrug resistance gene 1 (MDRI) was
examined in 74 patients with human immunodeficiency virus who initiated atazanavir …